{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:59:42Z","timestamp":1790765982460,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["MH085098-01"],"award-info":[{"award-number":["MH085098-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.biopsych.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T13:02:26Z","timestamp":1334754146000},"page":"331-338","source":"Crossref","is-referenced-by-count":267,"title":["Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression"],"prefix":"10.1016","volume":"72","author":[{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Brutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Laje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Luckenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarajya L. Vattem","family":"Venkata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving W.","family":"Wainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.03.004_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.mp.4001777","article-title":"Cure therapeutics and strategic prevention: Raising the bar for mental health research","volume":"11","author":"Insel","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: A new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2012.03.004_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.03.004_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.03.004_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.03.004_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/npp.2010.24","article-title":"Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine","volume":"35","author":"Salvadore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.004_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: A neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1017\/S0033291709991619","article-title":"Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: Implications for antidepressant effect","volume":"40","author":"Horacek","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2012.03.004_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0006-3223(00)01037-4","article-title":"Long-term outcome of patients who receive ketamine during research","volume":"49","author":"Lahti","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers","volume":"57","author":"White","year":"1985","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.biopsych.2012.03.004_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.004_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1517\/17425255.2011.597740","article-title":"Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism","volume":"7","author":"Porcelli","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.biopsych.2012.03.004_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/dmd.30.7.853","article-title":"Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes","volume":"30","author":"Hijazi","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.biopsych.2012.03.004_bib21","first-page":"887","article-title":"Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes","volume":"29","author":"Yanagihara","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.biopsych.2012.03.004_bib22","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1016\/j.chroma.2010.06.028","article-title":"Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro","volume":"1217","author":"Portmann","year":"2010","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.biopsych.2012.03.004_bib23","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/jm00161a043","article-title":"Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine","volume":"29","author":"Leung","year":"1986","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2012.03.004_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1460-9592.2007.02257.x","article-title":"Modeling the norketamine metabolite in children and the implications for analgesia","volume":"17","author":"Herd","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.biopsych.2012.03.004_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pbb.2008.05.011","article-title":"Effects of norketamine enantiomers in rodent models of persistent pain","volume":"90","author":"Holtman","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2012.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2012.04198.x","article-title":"Simultaneous population pharmacokinetic modeling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression","author":"Zhao","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.004_bib27","series-title":"Structured Clinical Interview for the DSM-IV-TR Axis I Disorders-Patient Edition","author":"First","year":"2002"},{"key":"10.1016\/j.biopsych.2012.03.004_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symtpoms to a single intravenous infusion of ketamine vs add-on riluzole: Results from a four-week, double-blind, placebo-controlled study","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.004_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopsych.2008.09.029","article-title":"Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"65","author":"Phelps","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.004_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.biopsych.2012.03.004_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.biopsych.2012.03.004_bib33","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.talanta.2010.08.005","article-title":"A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome","volume":"82","author":"Moaddel","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.biopsych.2012.03.004_bib34","first-page":"183","article-title":"The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives","volume":"320","author":"Sim","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.biopsych.2012.03.004_bib35","first-page":"179","article-title":"PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base","volume":"311","author":"Thorn","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.biopsych.2012.03.004_bib36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1373\/clinchem.2004.031708","article-title":"Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping","volume":"50","author":"Jacob","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2012.03.004_bib37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/ALN.0b013e3181b437b1","article-title":"S(+)-ketamine effect on experimental pain and cardiac output: A population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers","volume":"111","author":"Sigtermans","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2012.03.004_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","article-title":"In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: Preferential inhibition of cytochrome P450 2C9 (CYP2C9)","volume":"52","author":"Wen","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.004_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1389200013338676","article-title":"Hepatic cytochrome P450 regulation in disease states","volume":"2","author":"Cheng","year":"2001","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.biopsych.2012.03.004_bib40","first-page":"144","article-title":"Genotype\/phenotype comparisons: A probe for the effect of disease progression on drug metabolism","volume":"5","author":"Williams","year":"2002","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.biopsych.2012.03.004_bib41","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1172\/JCI117582","article-title":"Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism","volume":"94","author":"Shedlofsky","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2012.03.004_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.1.4.629","article-title":"Regulation of drug metabolism and disposition during inflammation and infection","volume":"1","author":"Renton","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312002211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312002211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T02:22:08Z","timestamp":1543026128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312002211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0006322312002211"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.03.004","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}